Albert Gris‐Oliver

Departament de Salut — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index1.4kcitations96works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PI3K/AKT/mTOR signaling in cancer(22), Colorectal Cancer Treatments and Studies(17), Histone Deacetylase Inhibitors Research(14), Protein Degradation and Inhibitors(14), Cancer Genomics and Diagnostics(13)

Publications96 total

Activated ATF6α is a hepatic tumour driver restricting immunosurveillance
Nature·2026Open Access
Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling
Nature Genetics·2026Open Access
Effective therapeutic targeting of <i>CTNNB1</i> ‐mutant hepatoblastoma with <scp>WNTinib</scp>
Molecular Oncology·2025Open Access
Data from E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma
2025Open Access
Supplementary Data 1 from E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma
2025Open Access
E7386 Enhances Lenvatinib’s Antitumor Activity in Preclinical Models and Human Hepatocellular Carcinoma
Clinical Cancer Research·2025· 1 citedOpen Access
Artificial intelligence predicts outcome-related molecular profiles and vascular invasion in hepatocellular carcinoma
JHEP Reports·2025Open Access
TOP-128-YI Efficacy of WNTinib, a novel selective therapeutic for CTNNB1mutant tumors, in preclinical models of hepatoblastoma
Journal of Hepatology·2025
SAT-113 The intratumoral microbiome in HCC and its impact on treatment response
Journal of Hepatology·2025
THU-077-YI E7386 enhances lenvatinib’s antitumor efficacy and upregulates ATF4 signalling in preclinical models and human hepatocellular carcinoma
Journal of Hepatology·2025· 1 cited
LBP-029-YI Spatial transcriptomics of the tumor microenvironment discriminates inflamed tumors responsive or resistant to atezolizumab + bevacizumab in patients with advanced HCC
Journal of Hepatology·2025Open Access
THU-078 Artificial intelligence-driven prediction of biology-related poor outcome and presence of vascular invasion in hepatocellular carcinoma
Journal of Hepatology·2025
Distinctive CD8+ T cell activation by antigen-presenting plasmacytoid dendritic cells compared to conventional dendritic cells
Cell Reports·2025· 3 citedOpen Access
Human-correlated genetic models identify precision therapy for liver cancer
Nature·2025· 17 citedOpen Access
Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Journal of Hepatology·2024· 21 citedOpen Access
76 (PB064): E7386 enhances both lenvatinib and anti-PD1 antitumor activity in HCC
European Journal of Cancer·2024
110 (PB098): Efficacy of WNTinib, a novel selective therapeutic for CTNNB1-mutant tumors, in preclinical models of hepatoblastoma
European Journal of Cancer·2024
Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC
JHEP Reports·2024· 3 citedOpen Access
TOP-507-YI Single-cell RNA sequencing-derived gene signatures reveal distinct response mechanisms to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Journal of Hepatology·2024· 1 cited
FRI-467 Efficacy of WNTinib, a novel selective therapeutic for CTNNB1 mutant tumors, in preclinical models of hepatoblastoma
Journal of Hepatology·2024
page 1 of 5Next →

Frequent Co-authors

Violeta Serra(34), Marta Guzmán(25), Judit Grueso(25), Maurizio Scaltriti(23), Yasir H. Ibrahim(21), Paolo Nucíforo(21), Rodrigo Dienstmann(20), Cristina Saura(18), Joaquı́n Arribas(18), Alejandra Bruna(16), Carlos Caldas(16), Olga Rodríguez(16), Marta Palafox(15), Gordon B. Mills(13), Fara Brasó‐Maristany(12), José Baselga(11), Pedram Razavi(11), Barry R. Davies(11), Mafalda Oliveira(11), Ana Vivancos(10)